1. Interleukin‐6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis. Issue 2 (February 2014) Authors: Thiolat, A.; Semerano, L.; Pers, Y. M.; Biton, J.; Lemeiter, D.; Portales, P.; Quentin, J.; Jorgensen, C.; Decker, P.; Boissier, M.‐C.; Louis‐Plence, P.; Bessis, N. Journal: Arthritis & rheumatology Issue: Volume 66:Issue 2(2014) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Protection from articular damage by passive or active anti‐tumour necrosis factor (TNF)‐α immunotherapy in human TNF‐α transgenic mice depends on anti‐TNF‐α antibody levels. (11th March 2013) Authors: Semerano, L.; Biton, J.; Delavallée, L.; Duvallet, E.; Assier, E.; Bessis, N.; Bernier, E.; Dhellin, O.; Grouard‐Vogel, G.; Boissier, M.‐C. Journal: Clinical and experimental immunology Issue: Volume 172:Number 1(2013:Apr.) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Reply. Issue 9 (September 2014) Authors: Thiolat, A.; Biton, J.; Decker, P.; Semerano, L.; Boissier, M.‐C.; Pers, Y. M.; Jorgensen, C.; Plence, P. Louis; Bessis, N. Journal: Arthritis & rheumatology Issue: Volume 66:Issue 9(2014) Page Start: 2640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗